Atlas Trials

Pachyonychia Congenita

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Pachyonychia Congenita

RecordFirmDate
Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmoplantar Keratoderma or Pachyonychia Congenita Diseases (NCT05435638)Orvida Pharma (formerly Kamari Pharma)2022-07-17
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita (NCT05180708)Palvella Therapeutics, Inc.2021-11-29
VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita (NCT04520750)Palvella Therapeutics, Inc.2020-09-01
Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita (NCT03920228)Palvella Therapeutics, Inc.2019-04-01
Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin (NCT02592954)Johns Hopkins University2015-09-01
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC) (NCT02152007)TransDerm, Inc.2014-01-01
Simvastatin Treatment of Pachyonychia Congenita (NCT01382511)Tel-Aviv Sourasky Medical Center2011-07-01
Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita (NCT00716014)Pachyonychia Congenita Project2008-01-01
International Pachyonychia Congenita Research Registry (NCT02321423)Pachyonychia Congenita Project2004-04-01

Track Pachyonychia Congenita automatically

Every clearance here is in the API, with alerts when new ones post.